Consensus Zai Lab Limited Deutsche Boerse AG

Stocks

1ZL

US98887Q1040

Pharmaceuticals

Market Closed - Deutsche Boerse AG 11:32:09 04/09/2026 am IST			5-day change	1st Jan Change
22.40 ^EUR	0.00%		-0.88%	+53.42%

04/09	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading	MT
02/09	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Evolution of the Average Target: Zai Lab Limited

Evolution of the Target Price: Zai Lab Limited

Changes in Analyst Recommendations: Zai Lab Limited

90a82a90.h6oW37GZDO6WRy5vgllWVwwbk4k6HEltnc5CD2_3mZA.8cV7jNXAaqamIWg38zMQBENP9ONpRHle8bwLbgCt_sPhzFW4htVpl64uWQ~b85ab77d36f4e083a7a23ef60fca830d

Analysts' recommendations: Zai Lab Limited

07/01	UBS Initiates Zai Lab at Buy With $35 Price Target	MT
05/11	Zai Lab updates on Amgen's bemarituzumab Phase 1B/3 Fortitude-102 study	RE
05/11	Zai Lab Limited Announces Update on Amgen's Bemarituzumab Phase 1B/3 Fortuda-102 Study	CI
13/25/13	JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating	MT
03/25/03	BofA Securities Downgrades Zai Lab to Neutral	MT
12/24/12	JPMorgan Cuts Price Target on Zai Lab to $38 From $43, Maintains Overweight Rating	MT
14/23/14	Morgan Stanley Starts Coverage on Zai Lab with Overweight Rating, $47.50 Price Target	MT
26/23/26	Citigroup Adjusts Price Target on Zai Lab to $128 From $130, Maintains Buy Rating	MT
26/23/26	Goldman Sachs Lowers Price Target on Zai Lab to $73.34 From $82.47, Maintains Buy Rating	MT
10/23/10	Cantor Fitzgerald Initiates Coverage on Zai Lab With Overweight Rating, $70 Price Target	MT
12/23/12	BofA Adjusts Price Target on Zai Lab to $62.50 From $75, Maintains Buy Rating	MT
11/23/11	Citigroup Adjusts Price Target on Zai Lab to $130 From $138, Keeps Buy Rating	MT
16/23/16	JPMorgan Adjusts Price Target on Zai Lab to $70 From $79, Maintains Overweight Rating	MT
18/22/18	JPMorgan Chase Lowers Price Target on Zai Lab to $79 From $96, Maintains Overweight Rating	MT
11/22/11	Citigroup Adjusts Price Target on Zai Lab to $127 From $199, Maintains Buy Rating	MT
09/22/09	Citigroup Adjusts Zai Lab's Price Target to $199 From $193, Reiterates Buy Rating	MT
26/22/26	CSPC Pharma Shares Fall After Weaker 1Q Profit	DJ
12/22/12	Citigroup Adjusts Zai Lab Price Target to $193 From $198, Maintains Buy Rating	MT
11/22/11	SVB Securities Adjusts Zai Lab Price Target to $95 From $101, Maintains Outperform Rating	MT
06/22/06	Guggenheim Adjusts Price Target for Zai Lab to $85 From $134, Maintains Buy Rating	MT
21/22/21	SVB Leerink Adjusts Zai Lab Price Target to $101 From $102, Maintains Outperform Rating	MT
04/22/04	JPMorgan Lowers Zai Lab's Price Target to $112 From $136, Maintains Overweight Rating	MT
03/22/03	Analyst recommendations: Acushnet, Bristol-Myers Squibb, Intel, iQIYI, Polymetal...
03/22/03	SVB Leerink Adjusts Zai Lab Price Target to $102 From $194, Maintains Outperform Rating	MT
04/21/04	Citigroup Raises Price Target for Zai Lab to $231 From $217, Maintains Buy Rating	MT

More recommendations

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
ZAI LAB LIMITED	-	-	-	-
REGENERON PHARMACEUTICALS, INC.				+1.54%
CSL LIMITED				-2.77%
MODERNA, INC.				-19.96%
SAMSUNG BIOLOGICS CO.,LTD.				+35.97%
UCB				+35.33%
BIOGEN INC.				+7.26%
INCYTE CORPORATION				+0.78%
INNOVENT BIOLOGICS, INC.				+25.51%
SWEDISH ORPHAN BIOVITRUM AB				+9.41%
Average				+10.34%
Weighted average by Cap.				+8.17%